Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OX0V
|
||||
| Former ID |
DNC005883
|
||||
| Drug Name |
2-(4-ethylthiobenzimidazol-2-yl)quinoxaline
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527933] | ||
| Formula |
C17H14N4S
|
||||
| Canonical SMILES |
CCSC1=CC=CC2=C1N=C(N2)C3=NC4=CC=CC=C4N=C3
|
||||
| InChI |
1S/C17H14N4S/c1-2-22-15-9-5-8-13-16(15)21-17(20-13)14-10-18-11-6-3-4-7-12(11)19-14/h3-10H,2H2,1H3,(H,20,21)
|
||||
| InChIKey |
IHVQPVYBIZVMSJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [527933] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [527933] | ||
| Adenosine A3 receptor | Target Info | Inhibitor | [527933] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| RANKL Signaling Pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.